Tepotinib in patients with advanced NSCLC with MET exon 14 (METex14) skipping: Overall efficacy results from VISION cohort A Meeting Abstract


Authors: Mazieres, J.; Paik, P.; Felip, E.; Veillon, R.; Sakai, H.; Cortot, A.; Viteri, S.; Garassino, M.; Van Meerbeeck, J.; Raskin, J.; Thomas, M.; Morise, M.; Cho, B. C.; Conte, P.; Bruns, R.; Demuth, T.; Schumacher, K. M.; Le, X.
Abstract Title: Tepotinib in patients with advanced NSCLC with MET exon 14 (METex14) skipping: Overall efficacy results from VISION cohort A
Meeting Title: 2020 North America Conference on Lung Cancer
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 1 Suppl.
Meeting Dates: 2020 Oct 16-17
Meeting Location: Virtual
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-01-01
Start Page: S5
Language: English
ACCESSION: WOS:000610079600008
PROVIDER: wos
DOI: 10.1016/j.jtho.2020.10.028
Notes: Meeting Abstract: OA05.03 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik